<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 38-year-old male with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> at clinical stage IV failed to achieve complete remission (CR), and developed leukemic change </plain></SENT>
<SENT sid="1" pm="."><plain>After the patient was further treated with intensive chemotherapy for <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in the peripheral blood and bone marrow disappeared, but the bulky mass persisted </plain></SENT>
<SENT sid="2" pm="."><plain>Then, the patient received allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from his human lymphocyte antigen (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> A)-identical brother following high-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and 12 Gy total body irradiation, and the patient achieved CR with the disappearance of Bcl-2 rearrangement </plain></SENT>
<SENT sid="3" pm="."><plain>The patient is now alive in continuous CR for more than 19 months after allo-PBSCT </plain></SENT>
</text></document>